Results from that trial could come out next year after initial data from separate studies examining Zepbound as a potential treatment for other health conditions, including heart failure
For years, an injectable format was the only option for GLP-1 therapiesbut that has changed
Although both belong to the GLP-1 medicine family, their strength and action differ : Mounjaro: Dual action (GLP-1 + GIP), stronger potency Wegovy: GLP-1 only Different half-lives: meaning they stay in the body for different lengths of time Switching mg-for-mg could cause severe nausea, vomiting, or side effects
Fujita H, Taniai H, Murayama H, Ohshiro H, Hayashi H, Sato S et al
If you want to understand sermorelin's effectiveness, it's important to compare different delivery methods